Insights from multi-omics on GLP-1 receptor agonists in type 2 diabetes and obesity

Asma A. Elashi, Laila Hedaya, Viviana Maggio, Khaled Naja, Manfredi Rizzo, Mohamed A. Elrayess

Open source

DOI
10.3389/fphar.2026.1812193
Published
2026-10-13
Container
Frontiers in Pharmacology
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2026.1812193,
  title = {Insights from multi-omics on GLP-1 receptor agonists in type 2 diabetes and obesity},
  author = {Asma A. Elashi and Laila Hedaya and Viviana Maggio and Khaled Naja and Manfredi Rizzo and Mohamed A. Elrayess},
  year = {2026},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2026.1812193},
  url = {https://doi.org/10.3389/fphar.2026.1812193}
}

RIS

TY  - JOUR
TI  - Insights from multi-omics on GLP-1 receptor agonists in type 2 diabetes and obesity
AU  - Asma A. Elashi
AU  - Laila Hedaya
AU  - Viviana Maggio
AU  - Khaled Naja
AU  - Manfredi Rizzo
AU  - Mohamed A. Elrayess
PY  - 2026
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2026.1812193
UR  - https://doi.org/10.3389/fphar.2026.1812193
ER  - 

APA

Elashi, A. A., Hedaya, L., Maggio, V., Naja, K., Rizzo, M., & Elrayess, M. A. (2026). Insights from multi-omics on GLP-1 receptor agonists in type 2 diabetes and obesity. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2026.1812193

Source records